124 related articles for article (PubMed ID: 10917374)
21. Predicting response to rhDNase and hypertonic saline in children with cystic fibrosis.
Suri R; Metcalfe C; Wallis C; Bush A
Pediatr Pulmonol; 2004 Apr; 37(4):305-10. PubMed ID: 15022126
[TBL] [Abstract][Full Text] [Related]
22. rhDNase in cystic fibrosis.
Tyrrell JC; Lewis PA; Sheldon CD; Connett G
Thorax; 1999 Aug; 54(8):752. PubMed ID: 10490419
[No Abstract] [Full Text] [Related]
23. Effect of a short course of rhDNase on cough and mucociliary clearance in patients with cystic fibrosis.
Robinson M; Hemming AL; Moriarty C; Eberl S; Bye PT
Pediatr Pulmonol; 2000 Jul; 30(1):16-24. PubMed ID: 10862158
[TBL] [Abstract][Full Text] [Related]
24. Clinical trials of recombinant human DNase in cystic fibrosis patients.
Aitken ML
Monaldi Arch Chest Dis; 1993 Dec; 48(6):653-6. PubMed ID: 8124306
[TBL] [Abstract][Full Text] [Related]
25. A six-month study of growth and energy expenditure in children with cystic fibrosis taking a pulmonary inhalation medication (rhDNase).
Fung EB; Barden EM; Wasserman D; Zemel BS; Heinrich BT; Scanlin TF; Stallings VA
J Am Coll Nutr; 1999 Aug; 18(4):330-8. PubMed ID: 12038476
[TBL] [Abstract][Full Text] [Related]
26. rhDNase in cystic fibrosis.
Conway SP; Littlewood JM
Br J Hosp Med; 1997 Apr 16-May 6; 57(8):371-2. PubMed ID: 9274660
[TBL] [Abstract][Full Text] [Related]
27. Nationwide trends in the medical care costs of privately insured patients with cystic fibrosis (CF), 2001-2007.
Briesacher BA; Quittner AL; Fouayzi H; Zhang J; Swensen A
Pediatr Pulmonol; 2011 Aug; 46(8):770-6. PubMed ID: 21465674
[TBL] [Abstract][Full Text] [Related]
28. A comparative study of hypertonic saline, daily and alternate-day rhDNase in children with cystic fibrosis.
Suri R; Wallis C; Bush A; Thompson S; Normand C; Flather M; Grieve R; Metcalfe C; Lees B
Health Technol Assess; 2002; 6(34):iii, 1-60. PubMed ID: 12583821
[No Abstract] [Full Text] [Related]
29. Recombinant human DNase (rhDNase) in cystic fibrosis: is it cost effective?
Conway SP
Arch Dis Child; 1997 Jul; 77(1):1-3. PubMed ID: 9279142
[No Abstract] [Full Text] [Related]
30. A cost-effectiveness analysis of rhDNase in children with cystic fibrosis.
Grieve R; Thompson S; Normand C; Suri R; Bush A; Wallis C
Int J Technol Assess Health Care; 2003; 19(1):71-9. PubMed ID: 12701940
[TBL] [Abstract][Full Text] [Related]
31. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I.
King M; Dasgupta B; Tomkiewicz RP; Brown NE
Am J Respir Crit Care Med; 1997 Jul; 156(1):173-7. PubMed ID: 9230743
[TBL] [Abstract][Full Text] [Related]
32. [New pharmacological approaches: rhDNase].
Tournier G; Sardet A; Grosskopf C; Baculard A; Delaisi B
Rev Pneumol Clin; 1995; 51(3):193-200. PubMed ID: 7569583
[TBL] [Abstract][Full Text] [Related]
33. Innovative assessment of inpatient and pulmonary drug costs for children with cystic fibrosis.
Levy JF; Rosenberg MA; Farrell PM
Pediatr Pulmonol; 2016 Dec; 51(12):1295-1303. PubMed ID: 27740724
[TBL] [Abstract][Full Text] [Related]
34. Bolus inhalation of rhDNase with the AERx system in subjects with cystic fibrosis.
Geller D; Thipphawong J; Otulana B; Caplan D; Ericson D; Milgram L; Okikawa J; Quan J; Bowman CM
J Aerosol Med; 2003; 16(2):175-82. PubMed ID: 12823911
[TBL] [Abstract][Full Text] [Related]
35. New treatment strategies in cystic fibrosis: rhDNase.
Shah PL; Hodson ME
Monaldi Arch Chest Dis; 1996 Apr; 51(2):125-9. PubMed ID: 8680379
[TBL] [Abstract][Full Text] [Related]
36. Two years experience with recombinant human DNase I in the treatment of pulmonary disease in cystic fibrosis.
Shah PL; Scott SF; Geddes DM; Hodson ME
Respir Med; 1995 Aug; 89(7):499-502. PubMed ID: 7480980
[TBL] [Abstract][Full Text] [Related]
37. Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study.
Aitken ML; Burke W; McDonald G; Shak S; Montgomery AB; Smith A
JAMA; 1992 Apr; 267(14):1947-51. PubMed ID: 1548827
[TBL] [Abstract][Full Text] [Related]
38. No positive effect of rhdnase on the pulmonary colonization in children with cystic fibrosis.
Bonestroo HJ; Slieker MG; Arets HG
Monaldi Arch Chest Dis; 2010 Mar; 73(1):12-7. PubMed ID: 20499789
[TBL] [Abstract][Full Text] [Related]
39. Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbations.
Wilmott RW; Amin RS; Colin AA; DeVault A; Dozor AJ; Eigen H; Johnson C; Lester LA; McCoy K; McKean LP; Moss R; Nash ML; Jue CP; Regelmann W; Stokes DC; Fuchs HJ
Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1914-7. PubMed ID: 8665055
[TBL] [Abstract][Full Text] [Related]
40. Long-term effects of aerosolised rhDNase on pulmonary disease progression in patients with cystic fibrosis.
Milla CE
Thorax; 1998 Dec; 53(12):1014-7. PubMed ID: 10195070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
